Tag: Withings

ScanWatch – The Most Advanced Hybrid Smartwatch from Withings Becomes Commercially Available Across America

ScanWatch, which received FDA clearance for atrial fibrillation detection through ECG and measuring SpO2 levels from the wrist, becomes available in the United States ISSY-LES-MOULINEAUX, France, Nov. 9, 2021 /PRNewswire/ — Today, Withings, pioneers of the connected health revolution, begins U.S. sales of ScanWatch, […]

Withings Announces the FDA Clearance of ScanWatch — Its Most Medically Advanced Hybrid Smartwatch

ScanWatch becomes the first wearable device to receive FDA clearance for both atrial fibrillation detection through medical grade ECG and measuring SpO2 levels from the wrist ISSY-LES-MOULINEAUX, France, Oct. 12, 2021 /PRNewswire/ — Today, Withings, pioneers of the connected health revolution, is pleased to […]